Scalper1 News
Juno Therapeutics (JUNO) set a record as the most highly valued biotech IPO this year, with the stock jumping 62% as trading began Friday. The initial public offering raised $265 million, with the company selling 11 million shares at 24. Juno initially planned to sell 9.3 million shares in a range of 15 to 18, then increased that to a range of 21 to 23 on Tuesday. Prior to Juno pricing its shares late Thursday the IPO was said to have been Scalper1 News
Scalper1 News